Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer

CHEN Yiliang; ZHANG Yinxu; CHE Zhongguang

doi:10.7619/jcmp.20212087

Journal of Clinical Medicine in Practice > 2021 > 25(20): 73-77. > DOI: 10.7619/jcmp.20212087

CHEN Yiliang, ZHANG Yinxu, CHE Zhongguang. Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 73-77. DOI: 10.7619/jcmp.20212087

Citation:

PDF (656 KB)

Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer

1.
Graduate Training Base of Jinzhou Medical University, Dandong Central Hospital of Liaoning Province, Dandong, Liaoning, 118000
2.
the First Hospital Affiliated to Jinzhou Medical University, Jinzhou, Liaoning, 121000

More Information

Received Date: May 18, 2021
Available Online: November 15, 2021
Published Date: October 27, 2021

Graphical Abstract

Abstract

Abstract

Objective To investigate the effect of whole-course intestinal microecological intervention intestinal microecological intervention on complications after operation and during chemotherapy in patients with colon cancer.
Methods Seventy-nine patients with colon cancer were selected as study objects and were divided into intervention group (n=40) and control group (n=39) according to whether patients were treated with Bifidobacterium Triple Viable Bacteria Tablets. The control group received conventional radical resection of colon cancer and chemotherapy, and the intervention group received Bifidobacterium Triple Viable Bacteria Tablets from 5 days before surgery until the end of chemotherapy. Postoperative recovery of gastrointestinal function and occurrence of complications in both groups were recorded. Serum inflammatory response indexes were compared after operation and during chemotherapy.
Results The postoperative recovery time of anal exhaust and defecation time in the intervention group were significantly shorter compared with the control group (P < 0.05). The overall incidence of postoperative complications and the incidence of various types of complications during chemotherapy in the intervention group were lower than those in the control group (P < 0.05). Serum inflammatory indexes in the intervention group after surgery and during chemotherapy were significantly lower than those in the control group (P < 0.05).
Conclusion The administration of Bifidobacterium Triple Viable Bacteria Tablets for colon cancer patients during period of perioperation and chemotherapy can significantly shorten the time of postoperative gastrointestinal function recovery, and at the same time, it is beneficial to suppress inflammation, reduce the incidence of complications after radical resection of colon cancer and during chemotherapy, and help to promote the outcome of the disease.
- colon cancer,
- intestinal microecology,
- probiotics,
- postoperative complications,
- chemotherapy-induced complications

FullText(HTML)

References (28)

References

[1]	郑树, 张苏展, 黄彦钦. 结直肠癌研究30年回顾和现状[J]. 实用肿瘤杂志, 2016, 31(1): 2-5. https://www.cnki.com.cn/Article/CJFDTOTAL-SYZZ201601002.htm
[2]	田红英. 结肠癌根治术后肠道菌群差异性分析及对预后的影响[J]. 中国肛肠病杂志, 2020, 40(7): 11-13. doi: 10.3969/j.issn.1000-1174.2020.07.005
[3]	KORNMANN V, VAN RAMSHORST B, VAN DIEREN S, et al. Early complication detection after colorectal surgery (CONDOR): study protocol for a prospective clinical diagnostic study[J]. Int J Colorectal Dis, 2016, 31(2): 459-464. doi: 10.1007/s00384-015-2468-3
[4]	何毅, 张鸿, 何东生. 腹腔镜根治术与传统开腹手术治疗结肠癌的临床效果对比分析[J]. 科技通报, 2017, 33(3): 81-84. https://www.cnki.com.cn/Article/CJFDTOTAL-KJTB201703016.htm
[5]	刘娇, 冯觉平. 早期肠内营养对结肠癌患者化疗期间营养状况及免疫功能的影响[J]. 广西医学, 2016, 38(6): 888-890. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201606042.htm
[6]	张璐. 肥胖患者右半结肠癌腹腔镜完整结肠系膜切除术后肠道菌群变化及预后的影响因素[J]. 中国现代普通外科进展, 2020, 23(1): 31-35. https://www.cnki.com.cn/Article/CJFDTOTAL-PWJZ202001009.htm
[7]	FAUST K, RAES J. Microbial interactions: from networks to models[J]. Nat Rev Microbiol, 2012, 10(8): 538-550. doi: 10.1038/nrmicro2832
[8]	COKER O O, NAKATSU G, DAI R Z, et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer[J]. Gut, 2019, 68(4): 654-662. doi: 10.1136/gutjnl-2018-317178
[9]	何花, 李建华, 杜文志. 结肠癌患者肠道菌群分布与临床意义分析[J]. 中国卫生标准管理, 2019, 10(11): 83-86. doi: 10.3969/j.issn.1674-9316.2019.11.034
[10]	郭桂元, 黄子成, 林婵婵, 等. 结肠癌根治术后肠道菌群及益生菌干预对结肠癌预后的影响[J]. 第三军医大学学报, 2017, 39(23): 2293-2298. https://www.cnki.com.cn/Article/CJFDTOTAL-DSDX201723010.htm
[11]	KOTZAMPASSI K, STAVROU G, DAMORAKI G, et al. Randomized, double-blind, placebo-controlled study of the efficacy of four probiotics to modify the risk for postoperative complications in colorectal surgery[J]. Crit Care, 2015, 19(1): P390. doi: 10.1186/s13054-015-1108-1
[12]	TLASKALOVÁ-HOGENOVÁH, STÊPÁNKOVÁR, KOZÁKOVÁH, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases[J]. Cell Mol Immunol, 2011, 8(2): 110-120. doi: 10.1038/cmi.2010.67
[13]	SCARTONI D, DESIDERI I, GIACOMELLI I, et al. Nutritional supplement based on zinc, prebiotics, probiotics and vitamins to prevent radiation-related gastrointestinal disorders[J]. Anticancer Res, 2015, 35(10): 5687-5692.
[14]	刘丹, 粟文钊, 吴忠良. 双歧杆菌三联活菌联合XELOX化疗对大肠癌术后肠道菌群及免疫功能的影响[J]. 中国医药导报, 2019, 16(32): 119-122. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY201932030.htm
[15]	王利伟, 许建多. 微生物制剂联合粘连松解汤治疗结直肠癌术后早期炎性肠梗阻的临床观察[J]. 世界中西医结合杂志, 2020, 15(8): 1373-1377, 1382. https://www.cnki.com.cn/Article/CJFDTOTAL-SJZX202008001.htm
[16]	中华人民共和国国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020, 58(8): 561-585. doi: 10.3760/cma.j.cn112139-20200518-00390
[17]	国家卫生计生委合理用药专家委员会. 消化道恶性肿瘤合理用药指南[J]. 中国执业药师, 2017, 14(9): 5-54. doi: 10.3969/j.issn.2096-3327.2017.09.002
[18]	MARCHESI J R, ADAMS D H, FAVA F, et al. The gut microbiota and host health: a new clinical frontier[J]. Gut, 2016, 65(2): 330-339. doi: 10.1136/gutjnl-2015-309990
[19]	张巍远, 王玉柳明, 张宇坤, 等. 结肠癌患者术前肠道菌群特征与术后腹泻的关系研究[J]. 结直肠肛门外科, 2020, 26(3): 337-341. https://www.cnki.com.cn/Article/CJFDTOTAL-DCGM202003026.htm
[20]	岳宏宇, 丛春莉, 李艳梅. 肠道微生态与肠道疾病关系的研究进展[J]. 中国真菌学杂志, 2020, 15(4): 240-243. doi: 10.3969/j.issn.1673-3827.2020.04.014
[21]	严斌斌, 戴桂花, 王彬, 等. 肠癌患者肠道菌群分析及携带β-葡萄糖醛酸酶基因特征[J]. 北华大学学报: 自然科学版, 2020, 21(2): 184-187. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYY202002010.htm
[22]	罗绰, 黄明君, 王一琳, 等. 肠道菌群与结直肠癌研究进展[J]. 肠外与肠内营养, 2019, 26(6): 377-381. https://www.cnki.com.cn/Article/CJFDTOTAL-CWCN201906016.htm
[23]	PREIDIS G A, VERSALOVIC J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era[J]. Gastroenterology, 2009, 136(6): 2015-2031. doi: 10.1053/j.gastro.2009.01.072
[24]	SADAHIRO S, SUZUKI T, TANAKA A, et al. Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection: prospective randomized trial[J]. Surgery, 2014, 155(3): 493-503. doi: 10.1016/j.surg.2013.06.002
[25]	张艺璇, 周秀彦, 高湘曼. 益生菌干预对结肠癌患者术后化疗并发症、预后及肠道菌群的影响[J]. 现代消化及介入诊疗, 2020, 25(6): 768-771. doi: 10.3969/j.issn.1672-2159.2020.06.017
[26]	EWASCHUK J B, DIAZ H, MEDDINGS L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(5): G1025-G1034. doi: 10.1152/ajpgi.90227.2008
[27]	孙曦, 杨云生. 益生菌与肿瘤化疗相关研究进展[J]. 中国实用内科杂志, 2016, 36(9): 739-743. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201609005.htm
[28]	IIDA N, DZUTSEV A, STEWART C A, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment[J]. Science, 2013, 342(6161): 967-970. doi: 10.1126/science.1240527

Cited By

Get Citation

PDF

XML

Article views (284) PDF downloads (18)

Turn off MathJax

Article Contents

Abstract

References

Effect of intestinal microecological interventionon complications after operation and during chemotherapy in patients with colon cancer

Abstract

References

Catalog

Export File

Citation

Format

Content